Trinity Biotech (TRIB) announced results from its latest pre-pivotal clinical trial for its next-generation continuous glucose monitoring ...
Trinity Biotech plc has announced encouraging results from its recent pre-pivotal clinical trial of its next-generation continuous glucose monitoring (CGM) system, targeting diabetes management.
Trinity stock is trading higher on Tuesday after the company announced results from its pre-pivotal clinical trial for its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback